Persistence and Time to Next Treatment With Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke: A Real-World Study

被引：0
|
作者：
Narezkina, Anna [1 ]
Akhter, Nausheen [2 ]
Lu, Xiaoxiao [3 ]
Emond, Bruno [4 ]
Huang, Qing [3 ]
Panjabi, Sumeet [3 ]
Hilts, Annalise [4 ]
Lu, Stephanie [5 ]
Lafeuille, Helene [4 ]
Lafeuille, Marie-Helene [4 ]
Choi, Michael [6 ]
机构：
[1] Univ Calif San Diego Hlth, San Diego, CA USA
[2] Northwestern Med, Chicago, IL USA
[3] Janssen Sci Affairs LLC, Horsham, PA USA
[4] Anal Grp Inc, Montreal, PQ, Canada
[5] Anal Grp Inc, Menlo Pk, CA USA
[6] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
CLL; chronic lymphocytic leukemia/small lymphocytic lymphoma; Bruton's tyrosine kinase inhibitor; time to next treatment; treatment persistence; atrial fibrillation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-390
引用
收藏
页码：S276 / S277
页数：2
相关论文
共 50 条
  • [41] Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada
    Huang, Steven J.
    Gerrie, Alina S.
    Young, Sean
    Tucker, Tracy
    Bruyere, Helene
    Hrynchak, Monica
    Galbraith, Paul
    Al Tourah, Abdulwahab J.
    Dueck, Gregory
    Noble, Michael C.
    Ramadan, Khaled M.
    Tsang, Peter
    Hardy, Edward
    Sehn, Laurie
    Toze, Cynthia L.
    LEUKEMIA RESEARCH, 2020, 91
  • [42] Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma
    Munir, Talha
    Brown, Jennifer R.
    O'Brien, Susan
    Barrientos, Jacqueline C.
    Barr, Paul M.
    Reddy, Nishitha M.
    Coutre, Steven
    Tam, Constantine S.
    Mulligan, Stephen P.
    Jaeger, Ulrich
    Kipps, Thomas J.
    Moreno, Carol
    Montillo, Marco
    Burger, Jan A.
    Byrd, John C.
    Hillmen, Peter
    Dai, Sandra
    Szoke, Anita
    Dean, James P.
    Woyach, Jennifer A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : 1353 - 1363
  • [43] Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis
    Seymour, Erlene K.
    Ruterbusch, Julie J.
    Beebe-Dimmer, Jennifer L.
    Schiffer, Charles A.
    CANCER, 2019, 125 (01) : 135 - 143
  • [44] Treatment appropriateness of direct oral anticoagulants in patients with atrial fibrillation for stroke prevention: A real-world prospective study
    Pasebani, Yeganeh
    Rafati, Ali
    Dalouchi, Saied
    Bahadori, Mohammad Javad
    Ghoshouni, Hamed
    Haghjoo, Majid
    Fazelifar, Amir Farjam
    Alizadeh-Diz, Abolfath
    Madadi, Shabnam
    Kamali, Farzad
    Hadavand, Naser
    Talasaz, Azita H.
    Lip, Gregory Y. H.
    Emkanjoo, Zahra
    Sadeghipour, Parham
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 81 (01) : 163 - 172
  • [45] Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib
    Rogers, Kerry
    Lu, Xiaoxiao
    Emond, Bruno
    Ding, Zhijie
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Mavani, Heena
    Qureshi, Zaina
    Ghosh, Nilanjan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
  • [46] Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma
    Herishanu, Yair
    Levi, Shai
    Kamdjou, Talia
    Bornstein, Yotam
    Ram, Ron
    Benyamini, Noam
    Varon, David
    Avivi, Irit
    Perry, Chava
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : E1 - E4
  • [47] Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target
    Morabito, Fortunato
    Gentile, Massimo
    Seymour, John F.
    Polliack, Aaron
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3250 - 3256
  • [48] Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation A real-world experience
    Gorczyca, Iwona
    Jelonek, Olga
    Michalska, Anna
    Chrapek, Magdalena
    Walek, Pawel
    Wozakowska-Kaplon, Beata
    MEDICINE, 2020, 99 (29) : E21209
  • [49] Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario
    Seung, Soo Jin
    Hurry, Manjusha
    Hassan, Shazia
    Elnoursi, Ashlie
    Scheider, Krystin A. B.
    Wagner, Dennis
    Edwin, Jonathan J.
    Aw, Andrew T. W.
    CURRENT ONCOLOGY, 2021, 28 (06) : 4832 - 4844
  • [50] Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naive Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis
    Ronconi, Giulia
    Dondi, Letizia
    Calabria, Silvia
    Piccinni, Carlo
    Pedrini, Antonella
    Esposito, Immacolata
    Martini, Nello
    CLINICAL DRUG INVESTIGATION, 2021, 41 (07) : 595 - 604
12345